Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current HIV/AIDS Reports
Published in: Current HIV/AIDS Reports 6/2019

01-12-2019 | Human Immunodeficiency Virus | The Global Epidemic (SH Vermund, Section Editor)

History of the HIV Epidemic in China

Authors: Zunyou Wu, Junfang Chen, Sarah Robbins Scott, Jennifer M. McGoogan

Published in: Current HIV/AIDS Reports | Issue 6/2019

Login to get access

Abstract

Purpose of Review

This study aims to review the history of the human immunodeficiency virus (HIV) infection epidemic in China.

Recent Findings

The HIV infection epidemic in China has evolved significantly over the past 35 years, from initially exclusively within people who inject drugs (PWID), to outbreaks due to plasma collection contamination in the mid-1990s, to now almost exclusive transmission via sexual contact. The number of newly-diagnosed cases and the number HIV-related deaths have increased each year since 2004, coinciding with a massive scale-up of both HIV testing and antiretroviral therapy initiation. The proportion of cases diagnosed later in their disease progression has remained constant.

Summary

The initial outbreaks of HIV across China were identified quickly and the overall trends have been monitored. While the HIV epidemic among PWID has been well managed, the growing HIV epidemic via sexual contact has grown more complex and even more difficult to control.
Literature
1.
Sun X, Wang N, Li D, Zheng X, Qu S, Wang L, et al. The development of HIV/AIDS surveillance in China. AIDS. 2007;21(Suppl 8):S33–S8.PubMed
2.
Wu Z. Achievement of HIV/AIDS program in the past 30 years and challenges in China. Chinese Journal of Epidemiology. 2015;36(12):1329–31.PubMed
3.
•• Pisani E, Wu Z. HIV in China: 30 years in numbers. In: Wu Z, editor. HIV/AIDS in China- beyond the numbers (English). Singapore: People's Medical Publishing House, Springer; 2017. p. 119–37. This chapter provides detailed desription, in quantitative terms, of the achivements China has made in controlling its HIV/AIDS epidemic over the past three decades.
4.
Sun X, Lu F, Wu Z, Poundstone K, Zeng G, Xu P, et al. Evolution of information-driven HIV/AIDS policies in China. International journal of epidemiology. 2010;39 Suppl 2:ii4–13.PubMedPubMedCentral
5.
Yang X, Li X, Qiao S, Zhang Q, Shen X, Zhou Y. Immunological and virologic outcomes of people living with HIV in Guanxi, China: 2012-2017. PLoS One. 2019;14(3):e0213205.PubMedPubMedCentral
6.
Zhang F, Ma Y. Progress and challenges in China's free ART programme. Lancet HIV 2019;6(1):PE8-E9.
7.
Mao Y, Wu Z, Poundstone K, Wang C, Qin Q, Ma Y, et al. Development of a unified web-based national HIV/AIDS information system in China. International journal of epidemiology. 2010;39 Suppl 2:ii79–89.PubMedPubMedCentral
8.
Zeng Y, Fan J, Zhang Q, Wang P, Tang D, Zong S, et al. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China. AIDS Research. 1986;2(Supplement 1):S147–9.
9.
Jia Z, Wang L, Chen RY, Li D, Wang L, Qin Q, et al. Tracking the evolution of HIV/AIDS in China from 1989-2009 to inform future prevention and control efforts. PLoS One. 2011;6(10):e25671.PubMedPubMedCentral
10.
Zhang KL. Epidemiology of HIV in China- intravenous drug users, sex workers, and large mobile populations are high risk groups. BMJ. 2002;324(7341):803–4.PubMedCentral
11.
Ma Y, Li Z, Zhang K, Yang W, Ren X, Yang Y, et al. HIV infections were first time found among people who inject drugs in China. Chinese Journal of Epidemiology. 1990;11:184–5.
12.
Zhang J, Cheng H, Zhao S, Yang W, Ma Y, LI R, et al. An epidemiological study on HIV infection in Ruili County. Yunnan Province Chinese Journal of Epidemiology. 1991;12(1):9–11.
13.
Zhao S, Cheng H, Zhang J, Li Z, Ma Y, Kou J, et al. AIDS surveillance in Yunnan Province of China (1986-1990). Chinese Journal of Epidemiology. 1991;12(2):72–4.PubMed
14.
He N, Detels R. The HIV epidemic in China: history, response, and challenge. Cell Res. 2005;15(11–12):825–32.PubMed
15.
Ji G, Detels R, Wu Z, Yin Y. Correlates of HIV infection among former blood/plasma donors in rural China. AIDS. 2006;20(4):585–91.PubMed
16.
Wu Z, Liu Z, Detels R. HIV-1 infection in commercial plasma donors in China. Lancet. 1995;346(8966):61–2.PubMed
17.
Wu Z, Dong N, Guo W. Discovery and control of the HIV/AIDS epidemic among plasma donors in China. In: Li L, Zhan S, editors. Epidemiological research cases in China (English). Beijing: People's Medical Publishing House; 2008. p. 153–64.
18.
Chaddah A, Wu Z. Selling blood spreads HIV. In: Wu Z, editor. HIV/AIDS in China- beyond the numbers (English). Singapore: People's Medical Publishing House, Springer; 2017. p. 9–22.
19.
Ye M, Giri M. Prevalence and correlates of HIV infection among men who have sex with men: a multi-provincial cross-sectional study in the southwest of China. HIV AIDS (Auckl). 2018;10:167–75.
20.
Wu Z, Xu J, Liu E, Mao Y, Xiao Y, Sun X, et al. HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China. Clin Infect Dis. 2013;57(2):298–309.PubMedPubMedCentral
21.
National Center for AIDS/STD Control and Prevention, China CDC Annual Report of China National HIV/STD/HCV Comprehensive Prevention and Treatment Programs in 2018. Beijing: National Center for AIDS/STD control and prevention, China CDC; 2019.
22.
• Cui Y, Guo W, Li D, Wang L, Shi CX, Brookmeyer R, et al. Estimating HIV incidence among key affected populations in China from serial cross-sectional surveys in 2010–2014. J Int AIDS Soc. 2016;19(1):20609. This paper describes HIV prevalence among key poplations and gives an estimation of HIV incidence among commercial sex workers, people who inject drugs and men who have sex with men.PubMedPubMedCentral
23.
Pan X, Jiang J, Ma Q, Zhang J, Yang J, Chen W, et al. Outbreak of HIV infection linked to nosocomial transmission, China, 2016-2017. Emerg Infect Dis. 2018;24(12):2141–9.PubMedPubMedCentral
24.
Wu Z, Rou K, Detels R. Prevalence of HIV infection among former commercial plasma donors in rural eastern China. Health Policy Plan. 2001;16(1):41–6.PubMed
25.
Liu Z, Mei Z, Zheng X, Zhang W, Wang F, Zhou Y, et al. Investigation of HIV infection among donors who engaged in three underground plasma collection events in Central China. Chinese Journal of Epidemiology. 2000;21(6):466–7.
26.
Qian HZ, Vermund SH, Kaslow RA, Coffey CS, Chamot E, Yang Z, et al. Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China. AIDS. 2006;20(10):1429–35.PubMed
27.
Ministry of Health of the People's Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization. 2005 update on the HIV/AIDS epidemic and response in China. Beijing: National Center for AIDS/STD Prevention and Control, China CDC; 2005.
28.
Xiao Y, Kristensen S, Sun J, Lu L, Vermund SH. Expansion of HIV/AIDS in China: lessons from Yunnan Province. Soc Sci Med. 2007;64(3):665–75.PubMed
29.
Chu TX, Levy JA. Injection drug use and HIV/AIDS transmission in China. Cell Res. 2005;15:865–9.PubMed
30.
Zhang J, Cheng H, Duan S, Duan Y, Zhao S, Wang S, et al. Survey on the current situation of epidemic of HIV infection in Yunnan Province. Chinese Journal of Epidemiology. 1994;15(5):259–62.PubMed
31.
Sullivan SG, Wu Z. Rapid scale up of harm reduction in China. Int J Drug Policy. 2007;18(2):118–28.PubMed
32.
Yan C, Liau A, Wu Z. An overview of the history of epidemic of and response to HIV/AIDS in China: achievements and challenges. Chin Med J. 2009;122(19):2251–7.
33.
Wang L, Guo W, Li D, Ding Z, McGoogan J, Wang N, et al. HIV epidemic among drug users in China: 1995 to 2011. Addiction. 2015;110(1):20–8.PubMedPubMedCentral
34.
National Health and Family Planning Commission of the People's Republic of China. 2015 China AIDS response Progress report. Beijing: Chinese Health and Family Planning Commission; 2015.
35.
Chen Q, Sun Y, Sun W, Hao M, Li G, Su X, et al. Trends of HIV incidence and prevalence among men who have sex with men in Beijing, China: nine consecutive cross-sectional surveys, 2008-2016. PLoS One. 2018;13(8):e0201953.PubMedPubMedCentral
36.
37.
Jia Y, Aliyu MH. Huang ZJ. BioMed Research International: Dynamics of the HIV Epidemic in MSM; 2014.
38.
Sun X, Xiao Y, Peng Z, Wang N. Frequent implementation of interventions may increase HIV infections among MSM in China. Sci Rep. 2018;8:451.PubMedPubMedCentral
39.
Cui Y, Liau A, Wu ZY. An overview of the history of epidemic of and response to HIV/AIDS in China: achievements and challenges. Chin Med J. 2009;122(19):2251–7.PubMed
40.
• Wu Z. Characteristics of HIV sexually transmission and challenges for controlling the epidemic in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39(6):707-9. This paper provides an updated account of the charaterisics of HIV sexual transmission and the many challenges China faces in controlling its HIV/AIDS epidemic.
41.
He N, Duan S, Ding Y, Rou K, McGoogan JM, Jia M, et al. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan. China PLoS One. 2013;8(11):e77981.PubMed
42.
National Center for AIDS/STD Control and Prevention, China CDC. China National HIV/syphilis/HCV Surveillance Report in 2015. Beijing: National Center for AIDS/STD control and prevention, China CDC; 2015.
43.
Shan D, Yu MH, Yang J, Zhuang MH, Ning Z, Liu H, et al. Correlates of HIV infection among transgender women in two Chinese cities. Infect Dis Poverty. 2018;7(1):123.PubMedPubMedCentral
44.
Best J, Tang W, Zhang Y, Han L, Liu F, Huang S, et al. Sexual behaviors and HIV/syphilis testing among transgender individuals in China: implications for expanding HIV testing services. Sex Transm Dis. 2015;42(5):281–5.PubMedPubMedCentral
45.
Yang X, Zhao L, Wang L, Hao C, Gu Y, Song W, et al. Quality of life of transgender women from China and associated factors: a cross-sectional study. J Sex Med. 2016;13:977–87.PubMed
46.
Zeng H, Chow EP, Zhao Y, Wang Y, Tang M, Li L, et al. Prevention of mother-to-child HIV transmission cascade in China: a systematic review and meta-analysis. Sex Transm Infect. 2016;92(2):116–23.PubMed
47.
Jiang JR, Zhou YB, Li HT, Gao YQ, Zhang YL, Luo SS, et al. HIV epidemic among pregnant women in China, 2016: trend and spatial analysis. Zhonghua Yi Xue Za Zhi. 2018;98(41):3360–4.PubMed
48.
Wang A, Qiao Y, Dou L, Wang Q, Wang X, Su M, et al. Challenges of eliminating mother-to-child transmission of HIV, syphilis and hepatitis B in China: a cross-sectional survey. Lancet. 2018;392:S55.
49.
Wu Z, Rou K, Cui H. The HIV/AIDS epidemic in China: history, current strategies and future challenges. AIDS Educ Prev. 2004;16(3 Suppl A):7–17.PubMed
50.
Yang S, Wu J, Ding C, Cui Y, Zhou Y, Li Y, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study. Lancet Infect Dis. 2017;17(7):716–25.PubMedPubMedCentral
51.
Information Office, Ministry of Health. 2003 Notifiable diseases in China. Bulletin of Ministry of Health 2004:63–64.
52.
Information Office, Ministry of Health. Ministry of Health releases notifiable diseases in China in January 2009 And in 2008. Bulletin of Ministry of Health. 2009:65–67.
53.
Bureau of Disease Control, National Health Commission of the People's Republic of China. Summary of 2018 notifiable diseases in China Beijing: National Health Commission of the People's Republic of China; 2019 [.
54.
Gao D, Zou Z, Dong B, Zhang W, Chen T, Cui W, et al. Secular trends in HIV/AIDS mortality in China from 1990 to 2016: gender disparities. PLoS One. 2019;14(7):e0219689.PubMedPubMedCentral
Metadata
Title
History of the HIV Epidemic in China
Authors
Zunyou Wu
Junfang Chen
Sarah Robbins Scott
Jennifer M. McGoogan
Publication date
01-12-2019
Publisher
Springer US
Published in
Current HIV/AIDS Reports / Issue 6/2019
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-019-00471-4

Other articles of this Issue 6/2019

Current HIV/AIDS Reports 6/2019 Go to the issue

The Global Epidemic (SH Vermund, Section Editor)

Evolving HIV Epidemiology in Mainland China: 2009–2018

HIV Pathogenesis and Treatment (AL Landay and NS Utay, Section Editors)

Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework

Complications of HIV and Antiretroviral Therapy (GA McComsey, Section Editor)

Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era

Complications of HIV and Antiretroviral Therapy (GA McComsey, Section Editor)

Contemporary Lifestyle Modification Interventions to Improve Metabolic Comorbidities in HIV

Complications of HIV and Antiretroviral Therapy (GA McComsey, Section Editor)

Aging with HIV

The Global Epidemic (SH Vermund, Section Editor)

Interventions to improve the HIV continuum of care in China
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits